Amit Hasija - Jul 11, 2025 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
CFO & EVP of Corp. Development
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
MIST
Transactions as of
Jul 11, 2025
Transactions value $
$0
Form type
4
Date filed
7/15/2025, 04:15 PM
Previous filing
Jan 29, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hasija Amit CFO & EVP of Corp. Development C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, QUEBEC, CANADA /s/ Jason Minio, Attorney-in-Fact 2025-07-15 0001787700

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIST Common Shares Award +50K 50K Jul 11, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Series A Common Warrants (right to buy) Award +50K 50K Jul 11, 2025 Common Shares 50K $1.50 Direct F1, F2
transaction MIST Series B Common Warrants (right to buy) Award +50K 50K Jul 11, 2025 Common Shares 50K $1.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 50,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 50,000 shares of common stock.
F2 Fully vested and exercisable.